Log in to save to my catalogue

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochond...

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochond...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1930442068

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production

About this item

Full title

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-08, Vol.12 (8), p.e0183426-e0183426

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Oxidative stress has been demonstrated to be involved in the etiology of alcoholic fatty liver disease (AFLD). Previous studies had demonstrated that resveratrol (RES) could reduce oxidative stress by different mechanisms. However, the effect of RES on alcohol-induced fatty liver remains unclear. In the present study, a total of 48 male SD rats wer...

Alternative Titles

Full title

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1930442068

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1930442068

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0183426

How to access this item